Abstract: Compounds, polymers, crosslinked polymers and pharmaceutical compositions comprising the same may be derived from multi-amine monomers and multi-functional monomers having two or more amine reactive groups. Such compounds, polymers, crosslinked polymers and compositions may be used to treat hyperphosphatemia or to remove ions from the gastrointestinal tract of animals, including humans.

Abstract: Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.

Abstract: Disclosed is a pharmaceutical composition comprising a stable polyallylamine hydrochloride polymer in which between about 4% to about 12% by weight of the polymer is a chloride anion and a pharmaceutically acceptable carrier or diluent.

Abstract: Systems and methods automatically obtain contents and display the contents on location-specific display screens, based on content attributes associated with the screens. Associating content attributes (“tags”) with the screens allows administrators to specify the types of contents desired for display on the screens. For example, an establishment that caters to customers of a particular demographic (such as 21-27 year old singles, families with children, fans of rock-and-roll music, “bikers,” sports fans or ice cream lovers) may associate one or more content attributes (such as “dating,” “Disney,” “Led Zeppelin,” or “Red Sox”) with its display screen. The system then automatically obtains contents based on the attribute(s) and displays the contents on the screen. Patrons with mobile telephones or web-based users may send text messages for display on the screen or play interactive games displayed on the screen, as described in the incorporated patent application.

Abstract: A tubing centralizing apparatus has a centralizer body including opposing end portions, a central passage extending through the opposing end portions, and a plurality of apertures extending therethrough between its exterior side surface and the central passage. The apertures are uniformly spaced about a longitudinal axis of the central passage. Bow springs are mounted on the exterior side surface of the centralizer body such that a central portion of each one of the bow springs is bowed away from the centralizer body. The tubing sub is slideably positioned within the central passage of the centralizer body. One of the tubing joint collars is attached to each end portion of the tubing sub. The tubing joint collars and the centralizer body are jointly configured such that the tubing joint collars engage the centralizer body for constraining the tubing sub within the central passage of the centralizer body.

Abstract: The invention relates to methods for treating hypercholesterolemia and atherosclerosis, and reducing serum cholesterol in a mammal. The methods of the invention comprise administering to a mammal a first amount of a bile acid sequestrant compound which is an unsubstituted polydiallylamine polymer and a second amount of a cholesterol-lowering agent. The first and second amounts together comprise a therapeutically effective amount. The invention further relates to pharmaceutical compositions useful for the treatment of hypercholesterolemia and atherosclerosis, and for reducing serum cholesterol. The pharmaceutical compositions comprise a combination of a first amount of an unsubstituted polydiallylamine polymer compound and a second amount of a cholesterol-lowering agent. The first and second amounts comprise a therapeutically effective amount. The pharmaceutical compositions of the present invention may optionally contain a pharmaceutically acceptable carrier.

Abstract: A mobile telephone which can supply or post ‘pre-answer’ information which the device owner considers of relevance to a potential call recipient. This information enables a potential call recipient to be given useful information about a potential call before actually answering that call. The information is dynamic, unlike Caller ID information. Examples include: information about the subject of an intended voice call, a mood, a current activity, part or whole of a schedule of meetings or events, information about the urgency of an intended voice call, personal information, expected call duration, commercial inducements to a consumer to answer a call (special offers, loyalty points etc.), location information.

Abstract: Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.

Abstract: A pharmaceutical composition comprising an aliphatic amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable magnesium compound comprising a magnesium ion is disclosed. A method of treating hyperphosphatemia in a patient is also disclosed. The method comprises the step of administering to the subject an effective amount of the disclosed pharmaceutical composition.

Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.

Abstract: The invention relates to a method for removing bile salts from a patient in need thereof and compositions useful in the method. The method comprises administering to the patient a therapeutically effective amount of a salt of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer salt comprises the reaction product of crosslinked polymers, or salts and copolymers thereof having amine containing repeat units, with at least one aliphatic alkylating agent.

Abstract: According to one embodiment of the present invention, a method of controlling an image projector comprising a multi-color laser source, projection optics, an image sensor, and a movement detection device comprises the projection of an image onto a display surface with the image projector. During projection, a movement signal generated by movement detection device is monitored, the movement signal indicating positional displacement of the image projector. A test pattern image is projected onto the display surface using the image projector, wherein the test pattern image projection is initiated as a function of the monitored movement signal. Thereafter, the projected test pattern image is captured from the display surface using the image sensor. A comparison of projected test pattern image data and captured test pattern image data is used to modify the manner in which subsequent images are projected to correct color distortions represented in the captured test pattern image.

Abstract: Disclosed is a pharmaceutical composition comprising a stable polyallylamine hydrochloride polymer in which between about 4% to about 12% by weight of the polymer is a chloride anion and a pharmaceutically acceptable carrier or diluent.

Abstract: According to one embodiment of the present invention, a programmable light source comprises one or more semiconductor lasers, a wavelength conversion device, and a laser controller. The controller is programmed to operate the semiconductor laser using a modulated feedback control signal. The wavelength control signal is adjusted based on the results of a comparison of a detected intensity signal with a feedback signal to align the lasing wavelength with the conversion efficiency peak of the wavelength conversion device. Laser controllers and projections systems operating according to the control concepts of the present invention are also provided.

Abstract: Polymers and compositions utilizing such polymers are disclosed for treating hyperphosphatemia and other illnesses associated with elevated serum phosphate levels. Phosphate binding polymers, or a pharmaceutically acceptable salt of the polymers, comprise pendent groups extending from a backbone of the polymer. Each pendent group comprises at least two nitrogen-bearing functional groups which bind phosphate. Variations of such polymer and compositions are disclosed.

Abstract: Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.

Abstract: Disclosed is a phenyl boronic acid compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aryl group. Z and Z? are independently —O—, —NH— or —S—. X is an electron withdrawing group. R is a substituted or unsubstituted straight chained hydrocarbyl group optionally comprising one or more amine, ammonium, ether, thioether or phenylene linking groups and Y is —H, an amine, —[NH—(CH2)q]r—NH2, halogen, —CF3, thiol, ammonium, alcohol, —COOH, —SO3H, —OSO3H or phosphonium group covalently bonded to the terminal position of R. Each —NH— in —[NH—(CH2)q]r—NH2 is optionally N-alkylated or N,N-dialkylated and —NH2 in —[NH—CH2)q]r—NH2 is optionally N-alkylated, N,N-dialkylated or N,N,N-trialkylated. q is an integer from 2 to about 10 and r is an integer from 1 to about 5.

Abstract: According to one embodiment of the present invention, a programmable light source comprises one or more semiconductor lasers, a wavelength conversion device, and a laser controller. The controller is programmed to operate the semiconductor laser using a modulated feedback control signal. The wavelength control signal is adjusted based on the results of a comparison of a detected intensity signal with a feedback signal to align the lasing wavelength with the conversion efficiency peak of the wavelength conversion device. Laser controllers and projections systems operating according to the control concepts of the present invention are also provided.

Abstract: A system and method for providing and managing location-based interactive content, including messages sent to specific location-based screens via mobile communication devices or the Internet. The location-based screens are display devices connected to a central content server that may be a central website, by a first network that may be the Internet. Each location-based display device may be independently controlled by a communications management module at the central website. The communications management module includes software and hardware so that it may record a user's responses and may update any screen according to system policies.

Abstract: The invention relates to a method for removing bile salts from a patient in need thereof and compositions useful in the method. The method comprises administering to the patient a therapeutically effective amount of a salt of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer salt comprises the reaction product of crosslinked polymers, or salts and copolymers thereof having amine containing repeat units, with at least one aliphatic alkylating agent.